Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 390

1.

Prognostic value of plasma neutrophil gelatinase-associated lipocalin for mortality in patients with heart failure.

van Deursen VM, Damman K, Voors AA, van der Wal MH, Jaarsma T, van Veldhuisen DJ, Hillege HL.

Circ Heart Fail. 2014 Jan;7(1):35-42. doi: 10.1161/CIRCHEARTFAILURE.113.000242. Epub 2013 Dec 17.

2.

Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.

Palazzuoli A, Ruocco G, Pellegrini M, De Gori C, Del Castillo G, Franci B, Nuti R, Ronco C.

Am J Cardiol. 2015 Jul 1;116(1):104-11. doi: 10.1016/j.amjcard.2015.03.043. Epub 2015 Apr 8.

PMID:
25943992
3.

Neutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement.

Pronschinske KB, Qiu S, Wu C, Kato TS, Khawaja T, Takayama H, Naka Y, Templeton DL, George I, Farr MA, Mancini DM, Schulze PC.

J Heart Lung Transplant. 2014 Dec;33(12):1215-22. doi: 10.1016/j.healun.2014.06.007. Epub 2014 Jun 23.

4.

Plasma neutrophil gelatinase-associated lipocalin as a marker for the prediction of worsening renal function in children hospitalized for acute heart failure.

Elsharawy S, Raslan L, Morsy S, Hassan B, Khalifa N.

Saudi J Kidney Dis Transpl. 2016 Jan;27(1):49-54. doi: 10.4103/1319-2442.174071.

5.
6.

Plasma neutrophil gelatinase-associated lipocalin and kidney function decline and kidney disease-related clinical events in older women.

Lim WH, Lewis JR, Wong G, Teo R, Lim EM, Byrnes E, Prince RL.

Am J Nephrol. 2015;41(2):156-64. doi: 10.1159/000380831. Epub 2015 Mar 25.

PMID:
25824561
8.

Admission plasma neutrophil gelatinase associated lipocalin (NGAL) predicts worsening renal function during hospitalization and post discharge outcome in patients with acute heart failure.

Palazzuoli A, Ruocco G, Beltrami M, Franci B, Pellegrini M, Lucani B, Nuti R, Ronco C.

Acute Card Care. 2014 Sep;16(3):93-101. doi: 10.3109/17482941.2014.911915. Epub 2014 May 16.

PMID:
24836558
9.

Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward.

Alvelos M, Pimentel R, Pinho E, Gomes A, Lourenço P, Teles MJ, Almeida P, Guimarães JT, Bettencourt P.

Clin J Am Soc Nephrol. 2011 Mar;6(3):476-81. doi: 10.2215/CJN.06140710. Epub 2010 Nov 29.

10.

Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial.

Maisel AS, Mueller C, Fitzgerald R, Brikhan R, Hiestand BC, Iqbal N, Clopton P, van Veldhuisen DJ.

Eur J Heart Fail. 2011 Aug;13(8):846-51. doi: 10.1093/eurjhf/hfr087.

11.

Effects of atorvastatin on NGAL and cystatin C in chronic kidney disease: a post hoc analysis of the LORD trial.

Fassett RG, Robertson IK, Ball MJ, Geraghty DP, Cardinal JW, Coombes JS.

Nephrol Dial Transplant. 2012 Jan;27(1):182-9. doi: 10.1093/ndt/gfr193. Epub 2011 May 4.

PMID:
21543653
12.

Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease.

Shen SJ, Hu ZX, Li QH, Wang SM, Song CJ, Wu DD, He JL, Guan JC, Shan JP.

Nephrology (Carlton). 2014 Mar;19(3):129-35. doi: 10.1111/nep.12203.

PMID:
24397346
13.

Neutrophil gelatinase-associated lipocalin, cystatin C and eGFR indicate acute kidney injury and predict prognosis of patients with acute pulmonary embolism.

Kostrubiec M, Łabyk A, Pedowska-Włoszek J, Dzikowska-Diduch O, Wojciechowski A, Garlińska M, Ciurzyński M, Pruszczyk P.

Heart. 2012 Aug;98(16):1221-8. doi: 10.1136/heartjnl-2012-301884. Epub 2012 Jun 15.

PMID:
22705926
15.

Renal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failure.

Shrestha K, Borowski AG, Troughton RW, Thomas JD, Klein AL, Tang WH.

J Card Fail. 2011 Jun;17(6):472-8. doi: 10.1016/j.cardfail.2011.02.003. Epub 2011 Mar 26.

18.

Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?

Matys U, Bachorzewska-Gajewska H, Malyszko J, Dobrzycki S.

Adv Med Sci. 2013;58(2):353-61. doi: 10.2478/v10039-012-0077-8.

PMID:
24384771
19.

Plasma neutrophil gelatinase-associated lipocalin predicts major adverse cardiovascular events after cardiac care unit discharge.

Ito M, Doi K, Takahashi M, Koyama K, Myojo M, Hosoya Y, Kiyosue A, Ando J, Noiri E, Yahagi N, Hirata Y, Komuro I.

J Cardiol. 2016 Feb;67(2):184-91. doi: 10.1016/j.jjcc.2015.05.010. Epub 2015 Jul 27.

20.

Neutrophil Gelatinase--Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple Myeloma.

Papassotiriou GP, Kastritis E, Gkotzamanidou M, Christoulas D, Eleutherakis-Papaiakovou E, Migkou M, Gavriatopoulou M, Roussou M, Margeli A, Papassotiriou I, Dimopoulos MA, Terpos E.

Clin Lymphoma Myeloma Leuk. 2016 Jan;16(1):29-35. doi: 10.1016/j.clml.2015.10.003. Epub 2015 Nov 3.

PMID:
26632077

Supplemental Content

Support Center